It’s been said that the heterogeneity of Medical Affairs departments between companies (and even within companies) is magnitudes greater that that observed between R&D and Marketing departments in Pharma and Biotech.

The concept of a DFMM has been discussed informally for a number of years. In essence, it requires organisations to reassess their Field Medical team and activities on a regular basis (usually quarterly), evaluating structure and function against the evolving external environment and anticipated changes – both internal and external.